Participants report improved control over eating behavior and reduced emotional or stress-related eating
That perspective is especially understandable considering that more than half of US adults could be eligible for GLP-1 use either for diabetes, obesity, or heart conditions - the overall population who may want/need access to these drugs is large enough to be cause for concern for any payer - even those as large and well-funded as the US government
Participants will use the MyDataHelps app to check their eligibility, provide consent, complete surveys, order research materials and receive compensation for participating in the study
Weight Watchers gives you access to both: Med+ members who engaged regularly with the GLP-1 Success Program lost 29.1% more body weight , on average, in 12 months than those who did not engage in behavioral support.^ ^Based on an internal analysis of 3,325 members who requested at least 1 GLP-1 medication refill through Weight Watchers Med+ and self-reported both a starting weight and weight at week 52
Bariatric surgery often leads to a 60% to 70% reduction in excess body weight, while GLP-1 medications like semaglutide typically result in a 15-20% total body weight loss
What it cant replace And thats where dermal fillers and injectable biostimulators can pick up the slack
